Physician profile
Jayme B Perry
NPI 1902177082
$5,917.26
in general payments reported to CMS, 2019-2025
27 companies · $831 in 2025
The $831 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $548 · 2022: $1,322 · 2023: $2,498 · 2024: $717 · 2025: $831.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,536 · Travel and Lodging: $1,426 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,535.91 |
| Travel and Lodging | $1,426.26 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,361.49 | 2022-2023 | Axonics |
| Astellas Pharma US INC | $558.40 | 2021-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $520.46 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $318.19 | 2021-2025 | |
| Pfizer INC. | $300.08 | 2021-2025 | |
| Endo USA, INC. | $213.33 | 2024-2025 | Xiaflex, Aveed |
| Bayer Healthcare Pharmaceuticals INC. | $210.01 | 2023-2025 | |
| Endo Pharmaceuticals INC. | $181.82 | 2021-2024 | Xiaflex, Aveed |
| Teleflex LLC | $167.74 | 2021-2023 | Urolift |
| Myovant Sciences INC. | $142.78 | 2021-2022 | |
| Janssen Biotech, INC. | $127.79 | 2022-2024 | Erleada |
| Novartis Pharmaceuticals Corporation | $97.81 | 2023-2025 | |
| Myriad Genetic Laboratories, INC. | $94.71 | 2021 | |
| Seagen INC. | $84.99 | 2025 | |
| Urovant Sciences INC | $83.30 | 2021-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $65.57 | 2021 | |
| Dendreon Pharmaceuticals LLC | $52.27 | 2022-2025 | Provenge |
| Abc Home Medical Supply, INC. | $52.06 | 2025 | |
| Coloplast Corp | $48.31 | 2023-2024 | Speedicath |
| Allergan, INC. | $46.42 | 2021 | |
| Antares Pharma, INC. | $41.82 | 2021 | |
| Hollister Incorporated | $34.54 | 2022-2023 | Onli, Vapro, Infyna Chic |
| Olympus America INC. | $31.64 | 2023 | Itind System |
| Boston Scientific Corporation | $27.47 | 2025 | Spaceoar System |
| Convatec INC. | $24.06 | 2022 | |
| Verity Pharmaceuticals INC. | $15.99 | 2025 | Trelstar |
| Clarus Therapeutics INC. | $14.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayme Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.